UTPA is hosting three conferences this week that discuss health care issues

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

On Wednesday, March 26, UTPA’s Bioethics Research Conference will host several panels that discuss the ethical implications to many medical and health issues, including: “Keeping People Alive Against Their Will in Texas: Examining Cases Like Marlise Muñoz” and “Are Celebrities Killing Us? The Vaccination Scare and the Impact of Celebrities on Public Health.”

On Thursday, March 27, The College of Social and Behavioral Sciences will host its Eighth Annual Research Conference . This year’s focus is Health and Health Policy in the Social Sciences.

On Friday, March 28, The College of Health Sciences and Human Services will host its Second Annual MORE Health @UTPA, which will have presentations on medical research. MORE Health will conclude with a community health fair Saturday, March 29 at the UTPA Ballroom where participants can receive free health screenings and other services.

- Advertisement -

Below, please find a link to the agendas for the conferences.  Thank you all for your continued support of UTPA.

https://www.utpa.edu/features/more-health/

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -